ProgramsDPU Student Consulting ExperienceProjectsDevelop a Market Analysis of Companion Cancer Biomarker Diagnostics...

Project Title: Develop a Market Analysis of Companion Cancer Biomarker Diagnostics Development

Protean BioDiagnostics

Details
Project Title Develop a Market Analysis of Companion Cancer Biomarker Diagnostics Development
Project Topics Data Management Growth Strategy Marketing Research & Development
Skills & Expertise
Project Synopsis: Challenge/Opportunity
Protean BioDiagnostics is at the forefront of developing advanced cancer diagnostics, particularly in the companion diagnostics (CDx) space—tests that are essential for identifying which patients are most likely to benefit from specific targeted therapies. As cancer treatment becomes more personalized, emerging markets such as India, the Middle East, and Southeast Asia are rapidly expanding their oncology infrastructure and research capabilities.

This project offers graduate students an opportunity to support Protean BioDiagnostics in assessing the market potential, regional needs, and competitive landscape for companion diagnostics. The end goal is to identify untapped opportunities, key players, and possible strategic partners that will help expand Protean’s reach in these fast-developing regions.
Project Synopsis: Activities/Actions Required
  1. Conduct a market scan of India, the Middle East, and Southeast Asia to evaluate healthcare infrastructure, oncology innovation, and diagnostic accessibility.
  2. Identify current and emerging pharmaceutical companies in these regions developing targeted cancer therapies and immunotherapies.
  3. Map the landscape of companion diagnostics companies, research institutes, and clinical partners.
  4. Analyze competitors and market gaps in the companion diagnostics ecosystem.
  5. Assess regulatory and clinical trial infrastructure impacting diagnostics innovation in each region.
  6. Provide a regional breakdown of market potential and propose initial partnership outreach targets.
Project Synopsis: Expected Results
  • Completion of a comprehensive market landscape report segmented by region.

  • Identification of at least 10–15 relevant pharmaceutical companies and CDx innovators across the three regions.

  • SWOT or gap analysis of current competitors and unmet needs in diagnostics.

  • Partnership shortlist with rationale and value proposition alignment.

  • Strategic insights that can inform future business development, marketing, and R&D expansion.

Project Timeline

Touchpoints & Assignments Date Type

UPLOAD MILESOTNE #3 DELIVERABLE

 Jan 09 2021 Submission Required

UPLOAD MILESOTNE #1 DELIVERABLE

 Mar 08 2021 Submission Required

Program Kickoff

 Jul 27 2021 Event

TEMP CHECK #1 DUE

 Oct 08 2021 Evaluation

Professional Development Session with Greg Zlevor, Westwood International

OFFICIAL PROJECT KICKOFF @ 8:00 AM ET

TEMP CHECK #2 DUE

 Evaluation

Final Presentations

OFFICIAL PROJECT END

PEER EVALUATION DUE

 Evaluation

SELF EVALUATION DUE

 Evaluation

UPLOAD YOUR RESUME

 Submission Required

UPLOAD MILESOTNE #2 DELIVERABLE

 Submission Required

UPLOAD FINAL PRESENTATION

 Submission Required

PRE-KICKOFF Q&A @ 8:00 AM ET

UPLOAD FINAL REPORT

 Submission Required

REMINDER OF CONFIDENTIALITY

Teams Finalized & Shared with Industry Partner

KICKOFF EVALUATION DUE

 Evaluation